NCT02669264 2021-05-24
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)
ADC Therapeutics S.A.
Phase 1 Terminated
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × loncastuximab tesirine × Other hematologic neoplasm × Clear all